New research has demonstrated how a novel vaccine strategy that boosts the immune system by rapidly producing antibodies against CHIKV, combined with a traditional DNA-based vaccine approach, can provide both short term and long term protection against the virus.
This full article appears on <a href="https://www.sciencedaily.com/releases/2016/03/160331154255.htm">Science Daily</a>